Cara Westmark
Associate Professor of Neurology, School of Medicine and Public Health
Preclinical research on dietary effects on mouse models of neurological disease with a focus on fragile X syndrome, autism and Alzheimer’s disease.

-
Comprehensive reviews in food science and food safety. pmid:42322656, doi:10.1111/1541-4337.70510
-
Nutrients. pmid:42280401, pmc:PMC13259054, doi:10.3390/nu18111758
-
International journal of molecular sciences. pmid:40649914, pmc:PMC12250412, doi:10.3390/ijms26136137
-
Frontiers in molecular neuroscience. pmid:40190341, pmc:PMC11968763, doi:10.3389/fnmol.2025.1520211
-
WMJ : official publication of the State Medical Society of Wisconsin. pmid:39908503
-
Nutrients. pmid:39125384, pmc:PMC11313885, doi:10.3390/nu16152503
-
International journal of molecular sciences. pmid:38928388, pmc:PMC11203515, doi:10.3390/ijms25126679
-
Nutrients. pmid:38257177, pmc:PMC10819477, doi:10.3390/nu16020284
-
ACS chemical neuroscience. pmid:38109073, pmc:PMC11127747, doi:10.1021/acschemneuro.3c00497
-
International review of neurobiology. pmid:37993176, doi:10.1016/bs.irn.2023.08.007
Dr. Westmark’s basic and translational science research laboratory studies pharmaceutical and dietary interventions for the treatment of fragile X syndrome, autism and Alzheimer’s disease with a focus on the synaptic function of amyloid beta protein precursor (APP) and amyloid-beta. She employs mouse models of neurological disorders and human survey data to correlate promising treatments with improved behavioral (seizure, cognitive, hyperactivity/sleep) and biomarker data.